Announcement of Eyebright Medical Technology: The company's controlling shareholder, actual controller, chairman and general manager Jie Jiangbing, director and senior management personnel Wang Zhao and senior management personnel Jia Baoshan plan to use their own funds or self-raised funds to increase their holdings of the company's shares through the trading system of Shanghai Stock Exchange in a centralized bidding manner starting from June 20, 2024 for six months. The total amount of the proposed shareholding increase is no less than RMB 3 million and no more than RMB 6 million.
爱博医疗：公司控股股东及部分董事、高级管理人员计划增持股份
Eyebright Medical Technology (Beijing) Co., Ltd.: The company's controlling shareholder and some directors and senior management personnel plan to increase their shareholdings.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.